The fourth type is triple-negative breast cancer, an aggressive form of invasive breast cancer in which the cancer cells lack estrogen receptors (ER) or progesterone receptors (PR) and do not produce human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.